North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)

TIPRE00028871 | Pages: 104 | Pharmaceuticals | Jan 2025 | Type: Regional | Status: Published

The North America dry eye products market was valued at US$ 3,825.36 million in 2023 and is expected to reach US$ 5,587.77 million by 2031; it is estimated to register a CAGR of 4.9% from 2023 to 2031.

Rising Prevalence of Dry Eye Fuels North America Dry Eye Products Market

Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors and cataracts, respectively. The prevalence of dry eye is particularly rising in developed nations. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to an article published by the American Academy of Ophthalmology, DED affects approximately 1 in 11 people worldwide, with prevalence ranging from 5% to 50% at various ages. According to a press release by Alcon in 2022, the disease affects ~719 million people globally and ~38 million people in the US.

Progressive damage caused to the retina due to diabetic retinopathy further results in DED. According to an article published by the American Academy of Ophthalmology, ~191.0 million people globally are estimated to suffer from diabetic retinopathy by 2030. As per the Centers for Disease Control and Prevention (CDC), approximately 9.6 million people (across all ages) in the US were living with diabetic retinopathy in 2021. Thus, the increasing incidence of diabetic retinopathy is driving the growth of the dry eye products market.

North America Dry Eye Products Market Overview

The North America dry eye products market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing awareness of dry eyes disease (DED), growing aging population, technological advancements, and rising eye disease cases. Moreover, an easy availability of various drugs due to frequent launches of new drugs is one of the key factors propelling the dry eye products market growth in the region.

DED is a common but underdiagnosed condition in the US, and an increase in the population age can be associated with the surging prevalence of this disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as cataract, macular degeneration, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision in the US. Other common eye disorders include amblyopia and strabismus. Dry eye disease is expected to affect as many as 2.79 million US men by 2030. Thus, with the rising incidence of dry eye disease, the demand for therapeutic products is on the rise in the country. In January 2021, Kala Pharmaceuticals Inc. launched EYSUVIS 0.25% (loteprednol etabonate ophthalmic suspension) for the short-term (up to two weeks) treatment of dry eye disease symptoms. EYSUVIS is now available in national and regional pharmaceutical distribution centers across the US.

North America Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

Get more information on this report :

North America Dry Eye Products Market Segmentation  

The North America dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the North America dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest North America dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the North America dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest North America dry eye products market share in 2023.

By type, the North America dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger North America dry eye products market share in 2023.

Based on distribution channel, the North America dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest North America dry eye products market share in 2023.

By country, the North America dry eye products market is segmented into the US, Canada, and Mexico. The US dominated the North America dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG. are some of the leading companies operating in the North America dry eye products market.

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           North America Dry Eye Products Market – Key Market Dynamics

4.1       Market Drivers

4.1.1         Rising Prevalence of Dry Eye

4.1.2         Upsurge in Geriatric Population

4.2       Market Restraints

4.2.1         Side Effects of Eye Drops and Product Recalls

4.3       Market Opportunities

4.3.1         Increasing Initiatives for Eye Care Awareness

4.4       Future Trends

4.4.1         Ongoing Research and Growing Pipeline for Dry Eye Products

4.5       Impact of Drivers and Restraints:

5.           Dry Eye Products Market – North America Analysis

5.1       North America Dry Eye Products Market Revenue (US$ Million), 2021–2031

6.           North America Dry Eye Products Market Analysis – by Product

6.1       Overview

6.2       Artificial Tears

6.2.1         Overview

6.2.2         Artificial Tears: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

6.3       Anti-Inflammatory Drugs

6.3.1         Overview

6.3.2         Anti-Inflammatory Drugs: North America Dry Eye Products Market – Revenue and Forecast to 2031  (US$ Million)

6.3.2.1            North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs

6.4       Punctal Plugs

6.4.1         Overview

6.4.2         Punctal Plugs: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

6.4.2.1            North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs

6.5       Secretagogues

6.5.1         Overview

6.5.2         Secretagogues: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

6.6       Oral Omega Supplements

6.6.1         Overview

6.6.2         Oral Omega Supplements: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

6.7       Others

6.7.1         Overview

6.7.2         Others: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

7.           North America Dry Eye Products Market Analysis – by Dosage Form

7.1       Overview

7.2       Eye Drops

7.2.1         Overview

7.2.2         Eye Drops: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

7.3       Gels

7.3.1         Overview

7.3.2         Gels: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

7.4       Capsules and Tablets

7.4.1         Overview

7.4.2         Capsules and Tablets: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

7.5       Others

7.5.1         Overview

7.5.2         Others: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

8.           North America Dry Eye Products Market Analysis – by Type

8.1       Overview

8.2       OTC

8.2.1         Overview

8.2.2         OTC: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

8.3       Prescription

8.3.1         Overview

8.3.2         Prescription: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

9.           North America Dry Eye Products Market Analysis – by Distribution Channel

9.1       Overview

9.2       Retail Pharmacies

9.2.1         Overview

9.2.2         Retail Pharmacies: North America Dry Eye Products Market – Revenue and Forecast to 2031  (US$ Million)

9.3       Hospital Pharmacies

9.3.1         Overview

9.3.2         Hospital Pharmacies: North America Dry Eye Products Market – Revenue and Forecast to 2031  (US$ Million)

9.4       Online Pharmacies

9.4.1         Overview

9.4.2         Online Pharmacies: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10.        North America Dry Eye Products Market – Country Analysis

10.1     North America: Dry Eye Products Market

10.1.1       North America: Dry Eye Products Market – Revenue and Forecast Analysis – by Country

10.1.1.1          United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1        United States: Dry Eye Products Market Breakdown, by Product

10.1.1.1.1.1        United States: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs

10.1.1.1.1.2        United States: Dry Eye Products Market Breakdown, by Punctal Plugs

10.1.1.1.2        United States: Dry Eye Products Market Breakdown, by Dosage Form

10.1.1.1.3        United States: Dry Eye Products Market Breakdown, by Type

10.1.1.1.4        United States: Dry Eye Products Market Breakdown, by Distribution Channel

10.1.1.2          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1        Overview

10.1.1.2.2        Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.3        Canada: Dry Eye Products Market Breakdown, by Product

10.1.1.2.3.1        Canada: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs

10.1.1.2.3.2        Canada: Dry Eye Products Market Breakdown, by Punctal Plugs

10.1.1.2.4        Canada: Dry Eye Products Market Breakdown, by Dosage Form

10.1.1.2.5        Canada: Dry Eye Products Market Breakdown, by Type

10.1.1.2.6        Canada: Dry Eye Products Market Breakdown, by Distribution Channel

10.1.1.3          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1        Overview

10.1.1.3.2        Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.3        Mexico: Dry Eye Products Market Breakdown, by Product

10.1.1.3.3.1        Mexico: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs

10.1.1.3.3.2        Mexico: Dry Eye Products Market Breakdown, by Punctal Plugs

10.1.1.3.4        Mexico: Dry Eye Products Market Breakdown, by Dosage Form

10.1.1.3.5        Mexico: Dry Eye Products Market Breakdown, by Type

10.1.1.3.6        Mexico: Dry Eye Products Market Breakdown, by Distribution Channel

11.        Industry Landscape

11.1     Overview

11.2     Growth Strategies in the Dry Eye Products Market

11.3     Organic Growth Strategies

11.3.1       Overview

11.4     Inorganic Growth Strategies

11.4.1       Overview

12.        Company Profiles

12.1     Santen Pharmaceutical Co Ltd

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     Johnson & Johnson

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     OASIS Medical

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     URSAPHARM Arzneimittel GmbH

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Rohto Pharmaceutical Co Ltd

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     OCuSOFT Inc.

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Bausch Health Companies Inc

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     AbbVie Inc

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     Prestige Consumer Healthcare Inc.

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Farmigea SpA

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

12.11  Alcon AG

12.11.1    Key Facts

12.11.2    Business Description

12.11.3    Products and Services

12.11.4    Financial Overview

12.11.5    SWOT Analysis

12.11.6    Key Developments

13.        Appendix

13.1     About The Insight Partners

13.2     Glossary of Terms

 

 

 

 

List of Tables

Table 1.             North America Dry Eye Products Market Segmentation

Table 2.             North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs

Table 3.             North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs

Table 4.             United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product

Table 5.             United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs

Table 6.             United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs

Table 7.             United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form

Table 8.             United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 9.             United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel

Table 10.          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product

Table 11.          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs

Table 12.          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs

Table 13.          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form

Table 14.          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 15.          Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel

Table 16.          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Product

Table 17.          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs

Table 18.          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs

Table 19.          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form

Table 20.          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Type

Table 21.          Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Distribution Channel

Table 22.          Recent Organic Growth Strategies in the Dry Eye Products Market

Table 23.          Recent Inorganic Growth Strategies in the Dry Eye Products Market

Table 24.          Glossary of Terms

 

 

List of Figures

Figure 1.           North America Dry Eye Products Market Segmentation, by Country

Figure 2.           North America Dry Eye Products Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           North America Dry Eye Products Market Revenue (US$ Million), 2021–2031

Figure 5.           Dry Eye Products Market Share (%) – by Product (2023 and 2031)

Figure 6.           Artificial Tears: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.           Anti-Inflammatory Drugs: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.           Punctal Plugs: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.           Secretagogues: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.        Oral Omega Supplements: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.        Others: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.        North America Dry Eye Products Market Share (%) – by Dosage Form (2023 and 2031)

Figure 13.        Eye Drops: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.        Gels: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.        Capsules and Tablets: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.        Others: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17.        North America Dry Eye Products Market Share (%) – by Type (2023 and 2031)

Figure 18.        OTC: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.        Prescription: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20.        Dry Eye Products Market Share (%) – by Distribution Channel (2023 and 2031)

Figure 21.        Retail Pharmacies: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22.        Hospital Pharmacies: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23.        Online Pharmacies: North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 24.        North America: Dry Eye Products Market, by Key Country – Revenue (2023) (US$ Million)

Figure 25.        North America: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26.        United States: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 27.        Canada: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 28.        Mexico: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

Figure 29.        Growth Strategies in the Dry Eye Products Market

 

  1. Santen Pharmaceutical Co Ltd
  2. Johnson & Johnson
  3. OASIS Medical
  4. URSAPHARM Arzneimittel GmbH
  5. Rohto Pharmaceutical Co Ltd
  6. OCuSOFT Inc.
  7. Bausch Health Companies Inc
  8. AbbVie Inc
  9. Prestige Consumer Healthcare Inc.
  10. Farmigea SpA
  11. Alcon AG
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America dry eye products market.       
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the dry eye products market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440